Can a 16-Month-Old Receive Atarax or Rupatadine?
No, neither Atarax (hydroxyzine) nor rupatadine should be given to a 16-month-old child. Both medications carry significant safety concerns in this age group, with hydroxyzine posing particular risks for toxicity and neurodevelopmental effects, while rupatadine lacks adequate safety data below 2 years of age.
Hydroxyzine (Atarax) - Not Recommended
Hydroxyzine should be avoided in children under 2 years due to documented toxicity risks and potential long-term neurodevelopmental harm. 1
Key Safety Concerns:
Fatal toxicity risk: Between 1969-2006, first-generation antihistamines (including hydroxyzine) were associated with 69 pediatric fatalities, with 41 deaths occurring in children under 2 years. Drug overdose and toxicity were common, often resulting from medication errors or use of multiple products 1
Neurodevelopmental effects: A 2021 population-based study found that repeat prescriptions of hydroxyzine in preschool children were associated with significantly increased rates of:
- Tic disorders (OR 1.55)
- Anxiety disorders (OR 1.34)
- Conduct disturbances (OR 1.34)
- Non-significant trends toward ADHD and emotional disturbances 2
FDA advisory position: In October 2007, major pharmaceutical companies voluntarily removed OTC cough and cold medications containing antihistamines for children under 2 years, and the FDA's advisory committees recommended against use below 6 years 1
Clinical Pitfall:
While the FDA label states hydroxyzine can be used at "all ages," this conflicts with current guideline recommendations and safety data. The label predates the 2007 FDA advisory committee recommendations and subsequent safety analyses 1, 3.
Rupatadine (Rupall) - Not Approved for This Age
Rupatadine is only approved and studied in children 2 years and older 4, 5
- Clinical trials specifically excluded children under 2 years
- The only pediatric efficacy data comes from studies in children aged 2-11 years 5
- No safety or dosing information exists for infants under 24 months
Recommended Alternatives
Second-generation antihistamines with proven safety profiles in young children should be used instead:
- Cetirizine: Approved from 6 months of age, well-tolerated with excellent safety profile 1
- Desloratadine: Available for children 2 years and older 1
- Loratadine: Approved from 2 years of age 1
These second-generation antihistamines have been specifically shown to be well-tolerated in young children with very good safety profiles, unlike first-generation agents 1.
Important Distinction:
The guideline explicitly states that second-generation antihistamines (cetirizine, desloratadine, loratadine) "when used in young children have been shown to be well tolerated and to have a very good safety profile," in direct contrast to first-generation antihistamines like hydroxyzine which should be avoided below age 6 1.
For a 16-month-old requiring antihistamine therapy, cetirizine is the only evidence-based option with documented safety from 6 months of age.